Ritu Gupta

599 total citations
9 papers, 382 citations indexed

About

Ritu Gupta is a scholar working on Pharmaceutical Science, Biomaterials and Economics and Econometrics. According to data from OpenAlex, Ritu Gupta has authored 9 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Biomaterials and 2 papers in Economics and Econometrics. Recurrent topics in Ritu Gupta's work include Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Ritu Gupta is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Drug Solubulity and Delivery Systems (3 papers). Ritu Gupta collaborates with scholars based in United States, India and Spain. Ritu Gupta's co-authors include Huan Xie, Yuan Chen, Meenakshi Bajpai, Mahua Sarkar, Huan Xie, Yuan Chen, Ruhee Dere, Dong Liang and Jing Ma and has published in prestigious journals such as The FASEB Journal, Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology and Pharmaceuticals.

In The Last Decade

Ritu Gupta

8 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ritu Gupta United States 4 222 110 66 45 35 9 382
Sufia Naseem India 5 318 1.4× 179 1.6× 112 1.7× 71 1.6× 30 0.9× 10 561
Gity Behbudi Iran 9 91 0.4× 118 1.1× 55 0.8× 65 1.4× 18 0.5× 15 370
Alina Martirosyan Denmark 7 198 0.9× 60 0.5× 61 0.9× 60 1.3× 14 0.4× 9 343
Zaira I. González-Sánchez Dominican Republic 11 209 0.9× 91 0.8× 60 0.9× 32 0.7× 12 0.3× 17 341
Pal Patel India 8 175 0.8× 75 0.7× 84 1.3× 59 1.3× 11 0.3× 11 332
Katya M. Aguilar-Pérez Mexico 9 108 0.5× 99 0.9× 54 0.8× 80 1.8× 28 0.8× 12 384
Ankit Kumar Malik India 12 85 0.4× 149 1.4× 113 1.7× 74 1.6× 38 1.1× 22 377
Zhongyuan Guo China 10 161 0.7× 61 0.6× 58 0.9× 103 2.3× 24 0.7× 21 429
Asha Kumari India 13 251 1.1× 53 0.5× 57 0.9× 35 0.8× 19 0.5× 40 401
Adrian Frydrych Poland 7 143 0.6× 95 0.9× 53 0.8× 42 0.9× 6 0.2× 15 342

Countries citing papers authored by Ritu Gupta

Since Specialization
Citations

This map shows the geographic impact of Ritu Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritu Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritu Gupta more than expected).

Fields of papers citing papers by Ritu Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ritu Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritu Gupta. The network helps show where Ritu Gupta may publish in the future.

Co-authorship network of co-authors of Ritu Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Ritu Gupta. A scholar is included among the top collaborators of Ritu Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ritu Gupta. Ritu Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Gupta, Ritu, et al.. (2023). Enhancing the Efficiency of the Individual Case Safety Report (ICSR)Quality and Compliance through Automation. Current Drug Safety. 19(2). 255–260. 1 indexed citations
2.
Gupta, Ritu, Yuan Chen, Mahua Sarkar, & Huan Xie. (2022). Surfactant Mediated Accelerated and Discriminatory In Vitro Drug Release Method for PLGA Nanoparticles of Poorly Water-Soluble Drug. Pharmaceuticals. 15(12). 1489–1489. 10 indexed citations
3.
Gupta, Ritu, et al.. (2022). Design of Experiment (DOE) for Optimization of PLGA Nanoparticles. The FASEB Journal. 36(S1). 2 indexed citations
4.
Gupta, Ritu, et al.. (2021). Some fungal infestations of dried fishes in Cochin markets. AquaDocs (United Nations Educational, Scientific and Cultural Organization).
5.
Gupta, Ritu, Yuan Chen, & Huan Xie. (2021). In vitro dissolution considerations associated with nano drug delivery systems. Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology. 13(6). 25 indexed citations
6.
Chen, Yuan, Ritu Gupta, Jing Ma, et al.. (2021). Development and Validation of an LC–MS/MS Method for AC1LPSZG and Pharmacokinetics Application in Rats. Journal of Chromatographic Science. 60(1). 26–34. 3 indexed citations
7.
Gupta, Ritu & Huan Xie. (2018). Nanoparticles in Daily Life: Applications, Toxicity and Regulations. Journal of Environmental Pathology Toxicology and Oncology. 37(3). 209–230. 333 indexed citations
8.
Gupta, Ritu. (2017). Clinical Success versus Attrition of Investigational Pharmaceuticals: A Vignette. Critical Reviews in Therapeutic Drug Carrier Systems. 34(6). 527–549. 1 indexed citations
9.
Gupta, Ritu & Meenakshi Bajpai. (2013). Preparation and Physicochemical Characterization of Tizanidine Hydrochloride Nanoparticles. Journal of Pharmaceutical Research. 12(1). 15–15. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026